Biostar Pharmaceuticals, Inc. Loans Payable, Fair Value Disclosure
Biostar Pharmaceuticals, Inc. had Loans Payable, Fair Value Disclosure of $2.43 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Financial Instruments, Financial Liabilities, Balance Sheet Groupings
us-gaap:LoansPayableFairValueDisclosure · last filed 2017-11-20
- 2017-09-30: Loans Payable, Fair Value Disclosure $2.43M.
- 2017-06-30: Loans Payable, Fair Value Disclosure $2.38M.
- 2017-03-31: Loans Payable, Fair Value Disclosure $2.34M.
- 2016-12-31: Loans Payable, Fair Value Disclosure $2.33M; Loans Payable, Fair Value Disclosure as first filed $2.77M.
| Period end | Loans Payable, Fair Value Disclosure | Loans Payable, Fair Value Disclosure as first filed |
|---|---|---|
| 2017-09-30 | $2.43M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $2.38M 10-Q · filed 2017-11-15 | |
| 2017-03-31 | $2.34M 10-Q · filed 2017-05-19 | |
| 2016-12-31 | $2.33M 10-Q · filed 2017-11-20 | $2.77M 10-K · filed 2017-04-13 |
| 2016-09-30 | $2.42M 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $2.43M 10-Q · filed 2016-08-22 | |
| 2016-03-31 | $2.50M 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $2.33M 10-K · filed 2017-04-13 | $2.77M 10-K · filed 2016-04-14 |
| 2014-12-31 | $3.09M 10-K · filed 2016-04-14 |